Summary:
Summary Statement of Deficiencies D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on a review of patient test reports and an interview with the laboratory's technical consultant #2 (TC #2), the laboratory failed to include the testing laboratory's name and address of where patient samples sent to reference laboratories for D Rh(o) types, and Aptima Gonorrhea and Chlamydia tests were performed since the last recertification survey was performed on March 30, 2022. The laboratory sends approximately 150 specimens per year to reference laboratories. Findings include: 1. A review of patient test reports revealed the laboratory failed to ensure the name and address of the reference laboratory was included on patient test reports when the laboratory sent specimens to reference laboratories for D Rh(o) typing, and Aptima Gonorrhea and Chlamydia testing. 2.. An interview on October 9, 2024, at approximately 11:00 AM, with the laboratory's TC 2, confirmed the reference laboratory name and the address was not included on the patient test reports for specimens sent to reference laboratories for D Rh(o) typing, and Aptima Gonorrhea and Chlamydia testing. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --